Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 555.57% | -54.34% | 827.53% | -91.05% | 559.73% |
Total Depreciation and Amortization | 9.00% | 28.54% | 15.96% | -15.56% | 3.21% |
Total Amortization of Deferred Charges | 13.49% | 37.33% | -78.36% | 552.31% | 0.00% |
Total Other Non-Cash Items | -88.05% | 196.92% | -112.09% | -170.20% | 122.77% |
Change in Net Operating Assets | 147.63% | -1,003.68% | -90.63% | 303.48% | -152.93% |
Cash from Operations | 1,302.93% | -75.63% | -55.60% | 149.20% | -63.85% |
Capital Expenditure | 0.97% | 18.38% | 26.69% | -34.33% | 11.21% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 99.64% | -- | -- | -100.00% | 101.32% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -124.76% | 473.79% | 67.96% | -63.38% | 202.28% |
Cash from Investing | 92.99% | -8,789.86% | 67.84% | -906.28% | 104.55% |
Total Debt Issued | -83.16% | -15.17% | 346.81% | 104.68% | 47.62% |
Total Debt Repaid | 45.89% | 65.83% | -381.51% | -126.44% | -5.99% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -0.10% | 0.00% | 0.02% | -0.02% | 0.02% |
Other Financing Activities | 33.42% | 84.22% | -- | -- | 147.10% |
Cash from Financing | -111.66% | 1,046.40% | -1,733.86% | -63.19% | 133.01% |
Foreign Exchange rate Adjustments | 116.28% | -605.62% | 201.67% | -423.36% | 93.70% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -144.10% | 181.15% | -192.09% | 18.16% | 269.45% |